HuagongsheHuagongshe Chemistry Print Report · For research reference only
1,4-Dioxane hydrochloride → (R)-3-Fluoro-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidin-2-yl-methyl]dibenzo[b,e][1,4]oxazepine hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1,4-Dioxane hydrochloride | HCID 20443148 | — |
| Reactant | (R)-3-fluoro-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepine | HCID 69198718 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | (R)-3-Fluoro-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidin-2-yl-methyl]dibenzo[b,e][1,4]oxazepine hydrochloride | HCID 69200801 | — |
Reaction Steps
0.3 ml of 4 M hydrogen chloride/dioxane was added to a solution of (R)-3-fluoro-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidin-2-yl-methyl]dibenzo[b,e][1,4]oxazepine (300 mg, 0.7 mmol) in dichloromethane (5 ml), and they were stirred together for 30 minutes. The solvent was evaporated under reduced pressure. The obtained residue was solidified with a mixed solvent of hexane and ethyl acetate. The solid thus precipitated was taken by the filtration to obtain the title compound in the form of a brown solid (257 mg, 79%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07320973B2 |
| Source dataset | uspto-grants-2008_01 |
| ORD ID | ord-d26b0276299a41a8a3212b3cc4d7f9a9 |
| Source note | uspto-grants-2008_01 |